Tag: COPD
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
Significantly greater composite adverse outcome rates seen for long- versus short-term inhaled corticosteroid use for prevalent, inception cohorts
COPD Tied to Increased Risk for Death in Patients With Arthritis
Findings seen for both all-cause and cardiovascular disease mortality
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Lower risk for COPD exacerbations seen with SGLT-2 inhibitors and GLP-1 receptor agonists, but not with DPP-4 inhibitors
Injurious Falls Common in Last Years of Life With COPD
Odds for use of fall risk-increasing drugs higher in those with falls versus without
Beginning to Smoke Before Age 15 Increases Risk for COPD
Findings independent of cigarette pack years, current smoking status, secondhand smoke exposure
Low Birth Weight May Increase Risk for Later COPD
Maternal smoking had joint effect with low birth weight for COPD risk
Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol
Bidirectional Association Found Between Rheumatoid Arthritis, COPD
Significant association between RA and increased COPD risk seen in both genders, seropositive/seronegative RA
AI Can Accurately Diagnose and Stage COPD With Inspiratory-Only Chest CT
Inclusion of clinical data can improve accuracy of convolutional neural network-based model predictions
Benralizumab Beneficial for Eosinophilic Exacerbations of Asthma, COPD
Treatment failures occurred in significantly more patients receiving only prednisolone versus benralizumab
